搜尋結果 "#Teplizumab"

動態

查看更多結果

Mary Grace N. Tamio shared news

在 March 21 2024 at 07:49 PM 已編輯

Role of teplizumab, a humanized anti-CD3 monoclonal antibody, in managing newly diagnosed type 1 diabetes: an updated systematic review and meta-analysis

#teplizumab #antibody #diabetes #journals #articles

More info | ⬇️

Role of teplizumab, a humanized anti-CD3 monoclonal antibody, in managing newly diagnosed type 1 diabetes: an updated systematic review and meta-analysis
MethodsRandomized controlled trials (RCTs) involving patients with T1D receiving teplizumab in the intervention arm and pl...
0 0 0 0 0 0 0

留言

Like

分享
Mary Grace N. Tamio shared news

在 April 03 2023 at 04:24 PM 已編輯

Teplizumab: type 1 diabetes mellitus preventable?

#teplizumab #type1diabetes #diabetes #articles #journals

More info | ⬇️

Teplizumab: type 1 diabetes mellitus preventable?
Type 1 diabetes mellitus (T1DM) is an autoimmune condition driven by T lymphocytes that specifically declines the function...
0 0 0 0 0 0 0

留言

Like

分享
Mary Grace N. Tamio

在 November 25 2022 at 07:51 PM 已編輯

First drug that delays onset of type 1 diabetes approved by FDA

#type1diabetes #FDA #Teplizumab

More info | ⬇️
https://cn1699.com/news/first-drug-delays-onset-type-1-diabetes-approved-fda

First drug that delays onset of type 1 diabetes approved by FDA | CN1699
The US Food and Drug Administration (FDA) has approved the first drug that can delay the onset of type 1 diabetes. A recent trial has shown that...
0 0 0 0 0 0 0

留言

Like

分享

搜尋過濾器

搜尋結果 "#Teplizumab"

動態